CB Insights today announced that DexCare was included in its fifth-annual Digital Health 50 list for 2023, formerly known as the Digital Health 150. The recognition highlights the top 50 private digital health companies on a trajectory for success.
According to CB Insights, the 50 winners were selected from a pool of over 10K companies, including applicants and nominees. Recipients were chosen based on several factors, including CB Insights datasets — covering R&D activity, Mosaic scores, business relationships, software buyer transcripts, investor profiles, news sentiment analysis, competitive landscape, and team strength — along with criteria such as tech novelty, market potential, and impact on the industry.
Since its spin-out from Providence, DexCare has continued to gain momentum, including:
- Extended its virtual-care-market footprint by 34%;
- Reached more than 57 million patients;
- Saved health systems more than 42,000 hours of critical physician time; and
- In July 2023, closed a $75 million Series funding round led by ICONIQ Growth.
“DexCare is steadfast to solve today’s pain points, yet looks over the horizon to anticipate what’s next,” said Derek Streat, DexCare’s CEO. “Today, delivering access to care can be a doctor’s appointment, a telehealth visit, or a same-day procedure – but it’s ultimately about building pathways to wellness. We envision a world where DexCare powers the delivery of good health outcomes, including access to preventative regiments, treatments, and education. If we remain idle, we lose our edge, and our partners rely on us to stay two steps ahead.”
DexCare is a care-access platform to manage the logistics of digital care delivery. The platform enables healthcare systems to forecast and predict demand and manage how and where care is merchandized to consumers – throughout the digital ecosystem. Today, DexCare works with leading healthcare systems, including Kaiser Permanente, Providence, and Community Health Network.
— Quick facts about the 2023 Digital Health 50:
- Equity funding and deals: Overall, the cohort has raised $3.2B+ over 145 equity deals since 2018. This includes nearly $1.5B over 41 deals in 2023 YTD.
- Unicorns: This year’s list includes only 1 unicorn with a $1B+ valuation.
- Global Reach: This year’s winners represent 8 countries across the globe. Twenty-two percent are headquartered outside the US, including 3 from the United Kingdom, 2 from Israel, and 2 from Spain. Other countries represented include South Korea, Belgium, France, and Brazil.